According to our previous proteogenomicstudy of the Taiwan CancerMoonshot cohort, OCIAD2 was identified as highly expressed in patientswith lung adenocarcinoma and strongly associated with unfavorableprognosis. The gene discussed is OCIAD2; the disease is lung adenocarcinoma.